In 2004, Hospira was a relatively no-name biotech company. By 2015, it had pioneered a new form of injectable and was raking in 4.5 billion in revenue. Do you have the skill to spot the next shooting star in the biotech industry?
We are a team of industry vets that offer free advice to investors - spotting the fastest rising companies in biotech.
jeudi, novembre 29, 2018
From Hospira to Pfizer - picking a winner in biotech.
Inscription à :
Publier les commentaires (Atom)
Aucun commentaire:
Enregistrer un commentaire